Bought
Maintained
Sold
Other funds holding TECH
BCM
Axa's TECH Position: Q1 2023 in Review
Axa sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 10,508 shares — an estimated $871K sold.
Axa first reported a position in TECH in Q2 2013 and held it in 16 quarters. The position peaked at $2.71M in Q4 2013. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.
- Axa reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
- Axa sold 10,508 Bio-Techne shares in Q1 2023, an estimated $871K.
- Axa first reported a position in Bio-Techne in Q2 2013 and held it in 16 quarters.
- Axa's Bio-Techne position peaked at $2.71M in Q4 2013.
- 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.
Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.